scholarly journals Predicting co-morbidities in chemically sensitive individuals from exhaled breath analysis

2012 ◽  
Vol 5 (3) ◽  
pp. 123-126 ◽  
Author(s):  
Harold I. Zeliger ◽  
Yaqin Pan ◽  
William J. Rea

ABSTRACT The exhaled breath of more than four hundred patients who presented at the Environmental Health Center - Dallas with chemical sensitivity conditions were analyzed for the relative abundance of their breath chemical composition by gas chromatography and mass spectrometry for volatile and semi-volatile organic compounds. All presenting patients had no fewer than four and as many as eight co-morbid conditions. Surprisingly, almost all the exhaled breath analyses showed the presence of a preponderance of lipophilic aliphatic and aromatic hydrocarbons. The hydrophilic compounds present were almost entirely of natural origin, i.e. expected metabolites of foods. The lipophile, primarily C3 to C16 hydrocarbons and believed to have come from inhalation of polluted air, were, in all cases, present at concentrations far below those known to be toxic to humans, but caused sensitivity and signs of chemical overload. The co-morbid health effects observed are believed to be caused by the sequential absorption of lipophilic and hydrophilic chemicals; an initial absorption and retention of lipophile followed by a subsequent absorption of hydrophilic species facilitated by the retained lipophile to produce chemical mixtures that are toxic at very low levels. It is hypothesized that co-morbid conditions in chemically sensitive individuals can be predicted from analysis of their exhaled breath.

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Rosa Alba Sola Martínez ◽  
José María Pastor Hernández ◽  
Gema Lozano Terol ◽  
Julia Gallego-Jara ◽  
Luis García-Marcos ◽  
...  

AbstractThe noninvasive diagnosis and monitoring of high prevalence diseases such as cardiovascular diseases, cancers and chronic respiratory diseases are currently priority objectives in the area of health. In this regard, the analysis of volatile organic compounds (VOCs) has been identified as a potential noninvasive tool for the diagnosis and surveillance of several diseases. Despite the advantages of this strategy, it is not yet a routine clinical tool. The lack of reproducible protocols for each step of the biomarker discovery phase is an obstacle of the current state. Specifically, this issue is present at the data preprocessing step. Thus, an open source workflow for preprocessing the data obtained by the analysis of exhaled breath samples using gas chromatography coupled with single quadrupole mass spectrometry (GC/MS) is presented in this paper. This workflow is based on the connection of two approaches to transform raw data into a useful matrix for statistical analysis. Moreover, this workflow includes matching compounds from breath samples with a spectral library. Three free packages (xcms, cliqueMS and eRah) written in the language R are used for this purpose. Furthermore, this paper presents a suitable protocol for exhaled breath sample collection from infants under 2 years of age for GC/MS.


The Analyst ◽  
2021 ◽  
Vol 146 (1) ◽  
pp. 222-231
Author(s):  
Pouline M. P. van Oort ◽  
Iain R. White ◽  
Waqar Ahmed ◽  
Craig Johnson ◽  
Jonathan Bannard-Smith ◽  
...  

Exhaled breath analysis is a promising new diagnostic tool, but currently no standardised method for sampling is available in mechanically ventilated patients. We identified potential sources of bias as illustrated in this figure.


2013 ◽  
Vol 3 (2) ◽  
pp. 243-244
Author(s):  
Ranabir Pal ◽  
S Dahal ◽  
A Gurung

Sixty years ago, Nobel Prize winner Linus Pauling proposed the concept that human breath is a complex and dynamic gaseous mixture of more than 200 different endogenous volatile organic compounds (VOCs) that are continually being released in different quantities within the internal environment during health and disease. The researchers estimate that more than a thousand chemicals produced in different organ-systems as metabolic end products come out every minute through the respiratory tract. Volatile organic compounds and other products of oxidative stress are a big chunk among these exhaled breath elements.DOI: http://doi.dx.org/10.3126/nje.v3i2.8509


2014 ◽  
Vol 66 (4) ◽  
pp. 1529-1538 ◽  
Author(s):  
Bozidarka Zaric ◽  
Srdjan Petrovic ◽  
Milan Bjekic ◽  
Ivana Rajic ◽  
Aleksandar Popovic ◽  
...  

Analysis of volatile organic compounds (VOCs) in human breath can provide information about the current physiological state of an individual, such as clinical conditions and exposure to exogenous pollutants. The blood-borne VOCs present in exhaled breath offer the possibility of exploring physiological and pathological processes in a noninvasive way. However, the field of exhaled breath analysis is still in its infancy. We undertook this study in order to define interindividual variation and common compounds in breath VOCs of 48 young human volunteers. Alveolar breath samples were analyzed by automated thermal desorption, gas chromatography with flame ionization detector (FID) and electron capture detector (ECD) using SUPELCO standards with 66 compounds. Predominant compounds in the alveolar breath of analyzed subjects are ethylbenzene, 1-ethyl-4-methylbenzene, 1,2,4-trimethylbenzene and 1,3,5-trimethylbenzene (over 50% of the subjects). Isopropyl alcohol, propylene, acetone, ethanol were found as well. We detected substituted compounds in exhaled breath.


2013 ◽  
Vol 2013 ◽  
pp. 1-20 ◽  
Author(s):  
Attapon Cheepsattayakorn ◽  
Ruangrong Cheepsattayakorn

Today, exhaled nitric oxide has been studied the most, and most researches have now focusd on asthma. More than a thousand different volatile organic compounds have been observed in low concentrations in normal human breath. Alkanes and methylalkanes, the majority of breath volatile organic compounds, have been increasingly used by physicians as a novel method to diagnose many diseases without discomforts of invasive procedures. None of the individual exhaled volatile organic compound alone is specific for disease. Exhaled breath analysis techniques may be available to diagnose and monitor the diseases in home setting when their sensitivity and specificity are improved in the future.


Author(s):  
Yasir I. Syed ◽  
Chris O. Phillips ◽  
Juan J. Rodriguez ◽  
Neil Mac Parthalain ◽  
Ludmila I. Kuncheva ◽  
...  

Metabolites ◽  
2019 ◽  
Vol 9 (3) ◽  
pp. 52 ◽  
Author(s):  
Zhunan Jia ◽  
Abhijeet Patra ◽  
Viknish Kutty ◽  
Thirumalai Venkatesan

Breath analysis is a promising technique for lung cancer screening. Despite the rapid development of breathomics in the last four decades, no consistent, robust, and validated volatile organic compound (VOC) signature for lung cancer has been identified. This review summarizes the identified VOC biomarkers from both exhaled breath analysis and in vitro cultured lung cell lines. Both clinical and in vitro studies have produced inconsistent, and even contradictory, results. Methodological issues that lead to these inconsistencies are reviewed and discussed in detail. Recommendations on addressing specific issues for more accurate biomarker studies have also been made.


Sign in / Sign up

Export Citation Format

Share Document